Table 2.

Effect of yoganidra on blood pressure, Hs-CRP, and lipid profile among experimental and control group subjects.

Sl. no.	Parameters	Experimental group (n = 31)				Control group (n = 43)
		Pre (mean ± SD)	Post (mean ± SD)	Mean diff	p value	Pre (mean ± SD)	Post (mean ± SD)	Mean diff	p value
1	BMI	28.68 ± 3.91	28.29 ± 3.62	0.389	0.009∗	27.61 ± 4.77	27.58 ± 4.95	0.03	0.872
2	SBP	142.9 ± 16.46	118.68 ± 9.21	24.22	0.0001∗∗	134.29 ± 14.17	130.71 ± 16.21	3.58	0.114
3	DBP	89.84 ± 10.42	77.03 ± 6.47	12.8	0.0001∗∗	86.84 ± 10.13	84.16 ± 9.82	2.68	0.121
4	PR	80.61 ± 11.49	78.94 ± 9.05	1.677	0.247	84.16 ± 9.82	81.19 ± 11.73	−0.52	0.85
5	MAP	107.61 ± 11.07	90.92 ± 6.48	16.69	0.0001∗∗	102.58 ± 9.44	99.75 ± 11.23	2.83	0.072
6	Hs-CRP	2.21 ± 1.49	1.06 ± 0.82	−1.15	0.0001∗∗	1.22 ± 1.05	2.57 ± 1.71	1.35	0.0001∗
7	Trig	155.84 ± 195.56	158.71 ± 140.73	−2.87	0.858	131.24 ± 74.28	130.84 ± 54.63	0.4	0.971
8	Tot. Chol	184.94 ± 32.19	186.00 ± 33.65	−1.0645	0.806	175.04 ± 37.46	181.0 ± 34.86	−5.96	0.147
9	HDL	51.0 ± 11.93	53.97 ± 14.04	−2.968	0.359	52.64 ± 9.57	51.73 ± 12.50	0.91	0.77
10	LDL	95.83 ± 29.64	89.63 ± 28.40	6.2	0.297	92.76 ± 28.96	88.0 ± 31.90	4.76	0.384
11	VLDL	31.17 ± 39.11	31.74 ± 28.15	−0.574	0.858	26.25 ± 14.±86	26.17 ± 10.93	0.08	0.971

SD, standard deviation. ^∗Significant and ^∗∗highly significant (p value < 0.005).